Personalized Medicine Market Outlook 2035: Genomic Testing, Targeted Therapies & AI Creating New Opportunities


 

Market Overview

According to MarketGenics, the global Personalized Medicine Market was valued at USD 484.1 billion in 2025 and is projected to reach USD 1,006.2 billion by 2035, registering a CAGR of 7.6% during the forecast period. The market is expanding as genomic sequencing, biomarker discovery, targeted therapies, pharmacogenomics, companion diagnostics, and AI-driven healthcare analytics enable treatment strategies tailored to individual patient characteristics. Oncology is the leading application segment, accounting for approximately 42% of the market in 2025.

To obtain a free sample research report - https://marketgenics.co/download-report-sample/personalized-medicine-market-00494

Market Growth Drivers

Major growth drivers include advances in next-generation sequencing (NGS), genomic testing, biomarker discovery, pharmacogenomics, and targeted drug development. The increasing prevalence of cancer, cardiovascular diseases, and rare genetic conditions is strengthening demand for patient-specific treatment approaches. In addition, the integration of artificial intelligence, big-data analytics, multi-omics, companion diagnostics, and digital health platforms is improving patient selection, disease-risk assessment, clinical decision-making, and personalized therapy development.

Key Players

The competitive landscape is moderately consolidated, with the top five players accounting for more than 40% of the market share in 2025. Key players identified by MarketGenics include Abbott Laboratories, Agilent Technologies, Biogen, Caris Life Sciences, Danaher, Exact Sciences, F. Hoffmann-La Roche, Foundation Medicine, GE HealthCare, Guardant Health, Illumina, Natera, QIAGEN, Tempus AI, Thermo Fisher Scientific, and Veracyte. Competition is focused on genomic sequencing, precision diagnostics, companion diagnostics, biomarker testing, targeted therapies, and AI-enabled precision healthcare solutions.

Regional Insights

North America leads the global Personalized Medicine Market and is identified by MarketGenics as the most attractive region, supported by advanced healthcare systems, strong genomics research infrastructure, high healthcare spending, widespread adoption of precision diagnostics, and established biotechnology and pharmaceutical ecosystems. Asia Pacific is experiencing the fastest growth, driven by expanding genomic research programs, increasing healthcare digitization, growing genetic-testing awareness, and government-backed precision-medicine initiatives in countries such as China, Japan, and India. Europe is also advancing through investments in genomic medicine, targeted therapies, and precision healthcare infrastructure.

Related Reports:

AI Agents Market

Penetration Testing as Service Market

AI-powered Analytics Market

Soil Conditioners Market

Peptide Stabilization Market

Contact:
Mr. Debashish Roy
MarketGenics Global Research
800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States
USA: +1 (302) 303-2617
Email: sales@marketgenics.co
Website: https://marketgenics.co

Comments

Post a Comment

Popular posts from this blog

Fertilizers Market Size, Growth, Trends & Forecast 2026–2035

Image
  Market Overview The global Fertilizers Market was valued at approximately USD 279.9 billion in 2025 and is projected to reach USD 430.5 billion by 2035 , registering a CAGR of 4.4% during 2026–2035 . The market is driven by increasing global food demand, declining arable land, soil nutrient depletion, and the need to improve crop productivity. Nitrogenous fertilizers represent the largest product segment, while demand for specialty fertilizers, micronutrients, controlled-release fertilizers, bio-fertilizers, and enhanced-efficiency fertilizers is increasing as farmers focus on nutrient-use efficiency and sustainable agricultural practices. To obtain a free sample research report - https://marketgenics.co/download-report-sample/fertilizers-market-69005 Market Growth Drivers Rising population and growing food consumption are major factors supporting the Fertilizers Market . Farmers are increasingly required to improve crop yields from limited agricultural land, increasi...
Read more

Payment Orchestration Platform Market Outlook 2035: Opportunities Across North America, Europe & Asia-Pacific

Image
  Payment Orchestration Platform Market Overview According to MarketGenics Analysis , the global Payment Orchestration Platform Market is witnessing rapid growth, fueled by the expansion of digital commerce, increasing adoption of multi-payment ecosystems, and the growing need for secure, scalable, and optimized payment processing solutions. The market is estimated to be valued at USD 2.8 billion in 2025 and is projected to reach USD 10.8 billion by 2035 , registering a CAGR of 14.6% during the forecast period. Payment orchestration platforms provide businesses with a unified infrastructure to manage multiple payment gateways, payment service providers (PSPs), fraud detection tools, tokenization services, and cross-border payment methods through a single integration. These platforms enable intelligent payment routing, higher transaction success rates, lower operational costs, improved customer experiences, and enhanced regulatory compliance. The growing adoption of digital...
Read more

The Future of Rare Disease Treatment: Market Insights and Growth Analysis

Image
  Rare Disease Treatment Market (Global) Overview The market was valued at approximately USD 195–216 billion in 2024 and is projected to reach around USD 370+ billion by 2030 , growing at a CAGR of ~11–12% during the forecast period . The global rare disease treatment market is a fast-growing segment of the healthcare and biotechnology industry focused on therapies for conditions affecting very small patient populations. Although each disease impacts a limited number of individuals, collectively rare diseases represent a significant global healthcare burden. The market is expanding rapidly due to increasing genetic disorder detection, rising awareness, and strong regulatory incentives for orphan drug development . Advancements in biologics, gene therapies, and precision medicine are transforming treatment possibilities for previously untreatable conditions. Request a Free Sample Copy or View Report Summary: https://marketgenics.co/download-report-sample/rare-disease-trea...
Read more